What’s next for the global heparin market?

It is expected to witness a CAGR of 7.22% through 2028.

The global heparin market is projected to grow by $3.34b until 2028 amidst an increasing prevalence of coagulation disorders and a trend towards rising R&D activities and new therapeutic applications.

A Technavio report revealed that the sector is anticipated to witness a compound annual growth rate of 7.22% during the forecast period.

“Both unfractionated heparin, derived from animal sources like bovine and porcine, and plasma-derived therapies are popular,” it said.

In addition, the market is driven by developments in heparin formulations, particularly fractionated and low-molecular-weight variants for thrombosis management.

Key patient groups include the geriatric population, accident victims, and individuals with chronic diseases. The rise in orthopaedic disorders and surgical interventions has also spurred heparin use.